Competitive Advantage in Co-operation of Enterprises Using Kaizen Costing Concept in Times of Extraordinary Dangers

Abstract

Purpose: The main aim of the study is to examine empirically the possibility of the impact of the use of the concept of kaizen costing by enterprises on shaping a competitive advantage in crisis conditions in the process of creating cooperation with other economic entities from several countries. Design/ Methodology/Approach: A logarithmic model was used in the research. Authors test the influence of selected explanatory variables on the dependent variable which is the company's market value. Findings: The data used to build the econometric model come from the website of the Warsaw Stock Exchange, 400 companies in the form of joint stock companies were analyzed. The paper examined the greatest impact of such explanatory variables as sales revenues, other operating income, profit (loss) from operations, profit (loss) gross, assets, equity of the shareholders of the parent entity, core capital, long-term liabilities, short-term liabilities, financial flows, net cash flow and earnings before interest, taxes, depreciation and amortization (EBITDA) on the market value of enterprises cooperating with other companies and also using the kaizen costing concept in the face of the coronavirus pandemic. The data used in the research cover from the first quarter of 2020 to first quarter of 2021. Practical implications: The assembled empirical evidence shows that in times of extraordinary global dangers of survival and gaining a competitive advantage and, consequently, increasing the company's market value as a result of establishing cooperation, the use of recommendations resulting from the kaizen costing concept may be favorable. Originality/ Value: The paper contains an original study of a representative group of a group of companies of various sizes. The above variables positively determined the market value of 400 listed companies. This dependence was also confirmed by the high value of the coefficient of determination R 2 =92%, as well as very low p-values.